Taru S. Dutt

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models

Giulietta Maruggi, Corey P. Mallett, Jason W. Westerbeck et al. · Molecular Therapy · 2022 · 80 citations · Full text

A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae

Stephanie M. LaVergne, Sophia Stromberg, Bridget A. Baxter et al. · BMC Infectious Diseases · 2021 · 61 citations · Full text

Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis

Taru S. Dutt, Burton Karger, Amy Fox et al. · Cell Reports · 2022 · 26 citations · Full text

Pulmonary Tuberculosis, Humoral Response, Immunology +7

BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis

Sangeeta Tiwari, Taru S. Dutt, Bing Chen et al. · Vaccine · 2020 · 23 citations · Full text

Medical Microbiology, Pulmonary Tuberculosis, Clinical Strains +11

A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model

Izabela Ragan, Lindsay Hartson, Taru S. Dutt et al. · Vaccines · 2021 · 21 citations · Full text

Immunology, Novel Inactivation Method, Vaccine Candidate +17